A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Clinical trial NCT02807558 · COMPLETED
Trial details
- NCT number
- NCT02807558
- Sponsor
- Syros Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2023-01-25
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.